Central Executive Training and Behavioral Parent Training for Young Children with ADHD
Official title: Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
Run by Florida State University · NCT07784348 · Data updated 2026-11-12
This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Years to 8 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Florida State University Academic / other |
| Locations | 1 site (Tallahassee, Florida) |
| Status | Recruiting |
| Started | May 1, 2024 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT07784348 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children with a principal ADHD diagnosis and elevated ADHD symptoms reported by parents and teachers, without major neurological or developmental exclusions.
✕Probably not a fit
Children with significant comorbid conditions, intellectual disability, non-English language barriers, or active acute psychiatric crises may be less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study begins with a non-randomized comparison of Behavioral Parent Training (BPT) versus Central Executive Training (CET) in young children diagnosed with ADHD, using established behavioral scales. It then proceeds to a randomized controlled trial comparing CET plus BPT (CET+BPT) to CET alone to determine if the combination provides additional benefit. Participants are children with ADHD who meet specified behavioral and cognitive criteria, with caregivers and teachers contributing assessments. The study is led by Florida State University and involves collaboration with the National Institute of Mental Health, conducted at the Children's Learning Clinic in Tallahassee, FL.
Why it matters
Potential benefit: If successful, CET and CET+BPT could offer new behavioral strategies to improve attention and executive functioning in young children with ADHD.
How similar studies have gone: Previous non-randomized and randomized behavioral trainings in ADHD have shown promise, but the CET+BPT combination represents a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * principal ADHD diagnoses (via K-SADS); (b) parent BASC-3 ADHD Problems or ADHD-RS ADHD-Combined scale in clinical/borderline range (\>90th percentile) based on age and sex; (c) teacher BASC-3 ADHD Problems or ADHD-RS ADHD-Combined scale in clinical/borderline range based on age and sex Exclusion Criteria: * (a) gross neurological, sensory, or motor impairment; (b) history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with study participation (e.g., disruptive mood dysregulation, conduct, intermittent explosive, reactive attachment); (c) intellectual disability or WPPSI/WISC short-form FSIQ\<70; (d) conditions requiring acute intervention, e.g., active suicidality; and (e) non-English speaking child or parent.
Where it's running
-
Children's Learning Clinic at Florida State University
Tallahassee, Florida, United States Recruiting
Study contacts
- Principal investigator: Michael Kofler, PhD — Florida State University
- Study coordinator: Children's Learning Clinic
- Email: clc@psy.fsu.edu
- Phone: 850-645-7423
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers that predict medication-related side effects in children with ADHD
This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.
-
Group CBT vs. Activity Group for Adults with ADHD
This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.
-
Solriamfetol for ADHD in teens: see if it helps with focus
This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.
-
Solriamfetol for children with ADHD: a 6-week comparison to placebo
This trial tests whether solriamfetol can help children aged 6 to under 12 with ADHD, compared to placebo, over six weeks.
-
Impact of Sleep Timing and Duration on Teens with ADHD
This study tests how changing how long and when teens with ADHD sleep affects their attention and daily functioning.
-
Health, Equity, and Resilience in Girls and Women with ADHD Across the Lifespan
This study tests health and well-being measures in girls and women with and without ADHD across Canada to see how ADHD relates to life phases and experiences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.